KeyCorp Comments on Healthequity Inc’s Q1 2019 Earnings (HQY)
Healthequity Inc (NASDAQ:HQY) – Analysts at KeyCorp issued their Q1 2019 earnings per share (EPS) estimates for Healthequity in a report released on Thursday. KeyCorp analyst D. Hooker forecasts that the company will earn $0.19 per share for the quarter. KeyCorp also issued estimates for Healthequity’s Q2 2019 earnings at $0.19 EPS, Q3 2019 earnings at $0.17 EPS and Q4 2019 earnings at $0.13 EPS.
Healthequity (NASDAQ:HQY) last released its earnings results on Tuesday, December 5th. The company reported $0.17 EPS for the quarter, topping analysts’ consensus estimates of $0.13 by $0.04. The company had revenue of $56.80 million for the quarter, compared to the consensus estimate of $55.27 million. Healthequity had a return on equity of 14.47% and a net margin of 21.08%. Healthequity’s quarterly revenue was up 31.0% compared to the same quarter last year. During the same quarter last year, the business posted $0.10 EPS.
Shares of Healthequity (HQY) traded down $0.03 during midday trading on Monday, hitting $48.92. The company had a trading volume of 231,700 shares, compared to its average volume of 443,311. The company has a market cap of $2,970.00, a P/E ratio of 66.11, a price-to-earnings-growth ratio of 2.02 and a beta of 1.74. Healthequity has a 1-year low of $37.62 and a 1-year high of $55.31.
In related news, VP Darcy G. Mott sold 9,500 shares of Healthequity stock in a transaction on Friday, October 20th. The stock was sold at an average price of $49.90, for a total value of $474,050.00. Following the transaction, the vice president now directly owns 90,500 shares in the company, valued at approximately $4,515,950. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Ashley Dreier sold 10,000 shares of Healthequity stock in a transaction on Monday, December 4th. The stock was sold at an average price of $50.97, for a total value of $509,700.00. Following the completion of the transaction, the vice president now owns 15,652 shares in the company, valued at $797,782.44. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 1,116,434 shares of company stock worth $58,417,878. 19.00% of the stock is owned by insiders.
Several hedge funds and other institutional investors have recently modified their holdings of the stock. Atlantic Trust Group LLC grew its holdings in shares of Healthequity by 9.5% in the 3rd quarter. Atlantic Trust Group LLC now owns 296,002 shares of the company’s stock worth $14,972,000 after acquiring an additional 25,647 shares during the last quarter. Amussen Hunsaker Associates LLC grew its holdings in shares of Healthequity by 1.9% in the 3rd quarter. Amussen Hunsaker Associates LLC now owns 237,239 shares of the company’s stock worth $12,000,000 after acquiring an additional 4,493 shares during the last quarter. Piedmont Investment Advisors LLC grew its holdings in shares of Healthequity by 15.9% in the 3rd quarter. Piedmont Investment Advisors LLC now owns 11,105 shares of the company’s stock worth $562,000 after acquiring an additional 1,520 shares during the last quarter. California Public Employees Retirement System grew its holdings in shares of Healthequity by 4.0% in the 3rd quarter. California Public Employees Retirement System now owns 95,859 shares of the company’s stock worth $4,849,000 after acquiring an additional 3,659 shares during the last quarter. Finally, Crestline Management LP acquired a new position in shares of Healthequity in the 3rd quarter worth $1,543,000. Institutional investors and hedge funds own 98.25% of the company’s stock.
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.